Patients with metastatic esophageal squamous cell cancer face a dismal prognosis, as no effective standard chemotherapy exists. A research group in China investigated the efficacy, toxic reaction and survival period of Oxaliplatin combined with capecitabine in treatment of patients with in patients with metastatic esophageal squamous cell cancer, and assessed the efficacy, toxicity and survival of the combination therapy.
Full article >>
Thursday, March 5, 2009
Safe, Well-tolerated, And Effective Treatment For Metastatic Esophageal Cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment